X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA ALEMBIC LTD PLETHICO PHARMA/
ALEMBIC LTD
 
P/E (TTM) x -1.1 76.8 - View Chart
P/BV x 0.0 2.9 0.6% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 PLETHICO PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ALEMBIC LTD
Mar-16
PLETHICO PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs39553 747.9%   
Low Rs3129 106.8%   
Sales per share (Unadj.) Rs604.44.7 12,805.9%  
Earnings per share (Unadj.) Rs32.58.8 370.2%  
Cash flow per share (Unadj.) Rs51.39.0 570.1%  
Dividends per share (Unadj.) Rs00.15 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs473.627.7 1,707.9%  
Shares outstanding (eoy) m34.08267.03 12.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.48.7 4.1%   
Avg P/E ratio x6.64.7 140.2%  
P/CF ratio (eoy) x4.24.6 91.1%  
Price / Book Value ratio x0.51.5 30.4%  
Dividend payout %01.7 0.0%   
Avg Mkt Cap Rs m7,26210,962 66.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1,596238 670.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m20,5981,260 1,634.4%  
Other income Rs m386264 146.5%   
Total revenues Rs m20,9841,524 1,376.8%   
Gross profit Rs m2,81883 3,403.0%  
Depreciation Rs m64261 1,046.1%   
Interest Rs m1,5930 531,066.7%   
Profit before tax Rs m969285 339.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m-1386 -2,268.5%   
Profit after tax Rs m1,1072,343 47.2%  
Gross profit margin %13.76.6 208.2%  
Effective tax rate %-14.32.1 -667.3%   
Net profit margin %5.4185.9 2.9%  
BALANCE SHEET DATA
Current assets Rs m18,8771,689 1,117.8%   
Current liabilities Rs m11,896486 2,446.8%   
Net working cap to sales %33.995.4 35.5%  
Current ratio x1.63.5 45.7%  
Inventory Days Days36217 16.6%  
Debtors Days Days19881 244.1%  
Net fixed assets Rs m9,8611,624 607.1%   
Share capital Rs m341534 63.8%   
"Free" reserves Rs m12,3315,960 206.9%   
Net worth Rs m16,1397,404 218.0%   
Long term debt Rs m4,706104 4,511.8%   
Total assets Rs m33,1468,010 413.8%  
Interest coverage x1.6950.7 0.2%   
Debt to equity ratio x0.30 2,069.9%  
Sales to assets ratio x0.60.2 395.0%   
Return on assets %8.129.3 27.8%  
Return on equity %6.931.6 21.7%  
Return on capital %12.331.3 39.3%  
Exports to sales %21.42.9 726.0%   
Imports to sales %15.228.9 52.8%   
Exports (fob) Rs m4,40237 11,866.3%   
Imports (cif) Rs m3,136364 862.3%   
Fx inflow Rs m4,40237 11,866.3%   
Fx outflow Rs m3,184365 872.4%   
Net fx Rs m1,219-328 -371.7%   
CASH FLOW
From Operations Rs m2,437346 705.3%  
From Investments Rs m-6,265-48 13,161.1%  
From Financial Activity Rs m2,490-301 -827.3%  
Net Cashflow Rs m-1,337-3 44,572.0%  

Share Holding

Indian Promoters % 82.7 64.0 129.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 0.2 2,150.0%  
FIIs % 5.5 9.7 56.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 26.1 28.7%  
Shareholders   10,665 54,701 19.5%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare PLETHICO PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS